Skip to main content
Log in

Costs of breast cancer to US Medicare increase with disease stage at diagnosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Surveillance , Epidemiology, and End Results

Reference

  • Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis. European Journal of Health Economics : 20 May 2021. Available from: URL: https://doi.org/10.1007/s10198-021-01315-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs of breast cancer to US Medicare increase with disease stage at diagnosis. PharmacoEcon Outcomes News 879, 9 (2021). https://doi.org/10.1007/s40274-021-7732-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7732-x

Navigation